IRHYTHM TECH Stock Analysis, Valuation (NASDAQ:IRTC)

Add to My Stocks
$61.92 $1.63 (2.56%) IRTC stock closing price Mar 23, 2018 (Closing)
Watch Robo Advisor Video of IRTC Stock Analysis
Updated on : Mar 23, 2018
previous close
IRTC 61.9 (0%)
S&P 500 2588.3 (0%)
Closing Price On: Mar 23, 2018
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Information Systems
Sector :
5 Quarter Revenue
Revenue Growth
Compared to the industry
Operating Profit
Operating Margin:
Sector Average:
5 Quarter Net Profit
Net Margins
LTM Margin
Debt/Equity Ratio
Debt/Equity Ratio:
Compared to the industry
Cash Flow
Operating cash flow:
Net Income:
Recent Growth
Operating Margins
Net Margins
High Debt Burden
FCF Margin
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
Industry PS :
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
Return on Equity:
Free Cash Flow Margin:
Double Tap To Exit Full Screen

IRHYTHM TECH Stock Analysis

1 5 2

View the IRHYTHM TECH stock analysis video on Amigobulls. Our analyst opinion covering the buy and sell arguments for IRTC stock is shown in the video.

Note: Amigobulls stock rating is our opinion based on the historical performance of the company's fundamentals. It is not indicative of the future performance of the stock.

IRHYTHM TECH Stock Rating 2.2/5

We at Amigobulls use various financial measures including profit margins, revenue growth and dividends for IRTC stock analysis. IRHYTHM TECH valuation analysis is based on relative valuation multiples like PE ratio and price to sales ratio. IRHYTHM TECH stock rating encapsulates our opinion about the company based on the fundamentals.

Should you buy IRTC stock?

  • IRHYTHM TECH's revenue growth came in at 50.7% in 2017 Q4.

Should you sell IRTC stock?

  • IRHYTHM TECH registered a negative operating margin of -27.7% (average) over the Trailing Twelve Months (TTM).
  • IRHYTHM TECH registered an average TTM Net loss of -29.9%.
  • IRHYTHM TECH has a debt/equity ratio of  0.43, which is worse than the average in the Medical sector.
  • The company does not have profits. Hence the PE ratio is meaningless for IRTC stock.
  • The company is trading at a price to sales multiple of 14.6, which is overvalued in comparison to the Medical-Information Systems industry average multiple of 5.6.
  • IRHYTHM TECH's negative ROIC of -168% indicates operational inefficiency.
  • IRHYTHM TECH has a negative return on equity of -33.9%. This indicates that the firm is inefficient at generating profits.
  • The company has a negative free cash flow margin of -16.5%.

Comments on this video and IRHYTHM TECH stock

Amigobulls IRHYTHM TECH stock analysis helps in evaluating the financial statements of a company to arrive at a conclusion about the fair value of IRTC stock. Company's fundamentals remain one of the key driver of IRTC stock and helps investors in making good buy and sell decision.

Among the financials of the company, IRHYTHM TECH revenue growth along with the profit or net income give a clear picture of the financial health. One can also combine technical analysis and fundamental analysis to get a holistic picture about IRTC stock.